Chemed Corporation (CHE)
| Market Cap | 6.51B |
| Revenue (ttm) | 2.14B |
| Net Income (ttm) | 277.25M |
| Shares Out | 14.90M |
| EPS (ttm) | 17.95 |
| PE Ratio | 24.32 |
| Forward PE | 22.08 |
| Dividend | $1.46 (0.33%) |
| Ex-Dividend Date | Aug 12, 2022 |
| Volume | 82,731 |
| Open | 443.01 |
| Previous Close | 446.10 |
| Day's Range | 435.28 - 447.72 |
| 52-Week Range | 403.00 - 539.87 |
| Beta | 0.51 |
| Analysts | Buy |
| Price Target | 575.28 (+31.8%) |
| Earnings Date | Oct 26, 2022 |
About CHE
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in C... [Read more...]
Financial Performance
In 2021, Chemed's revenue was $2.14 billion, an increase of 2.87% compared to the previous year's $2.08 billion. Earnings were $268.55 million, a decrease of -15.94%.
Financial StatementsAnalyst Forecast
According to 8 analysts, the average rating for CHE stock is "Buy." The 12-month stock price forecast is 575.28, which is an increase of 31.78% from the latest price.
News
Chemed (CHE) Roto-Rooter Business Grows, VITAS Admission Dips
The performance of Chemed's (CHE) VITAS business is somewhat offset by a geographically weighted average Medicare reimbursement rate increase.
Chemed's (CHE) Roto-Rooter Growth Aids, Macro Challenges Ail
Chemed's (CHE) VITAS segment revenue decline during the second quarter gets somewhat offset by a geographically weighted average Medicare reimbursement rate increase of nearly 1.3%.
Here's Why You Should Hold on to Chemed (CHE) Stock Now
Investors are optimistic about Chemed's (CHE) better-than-expected earnings and impressive Roto-Rooter results.
PNTG vs. CHE: Which Stock Should Value Investors Buy Now?
PNTG vs. CHE: Which Stock Is the Better Value Option?
5 Stocks in Focus That Recently Hiked Their Dividends
Investors should consider stocks that have recently raised their dividend payments. These are: HRB, CHE, SU, OTEX, ESNT.
Chemed Corporation Declares Quarterly Dividend of 38 Cents
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 38-cents per share on the Company's capital stock, payabl...
Chemed (CHE) Q2 Earnings Surpass Estimates, Margins Grow
Chemed (CHE) reports better-than-expected earnings in the second quarter, with a robust performance by the Roto-Rooter segment driving the top line.
Chemed (CHE) Q2 Earnings Surpass Estimates
Chemed (CHE) delivered earnings and revenue surprises of 1.26% and 1.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemed Reports Second-Quarter 2022 Results
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the...
Here's Why You Should Retain Chemed (CHE) Stock For Now
Investors are optimistic about Chemed (CHE) owing to the robust demand for Roto-Rooter services and the ongoing rebound in senior housing admissions.
Chemed To Report Second-Quarter 2022 Earnings July 27, Related Conference Call To Be Held On July 28
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the second quarter ended June 30, 2022, on Wednesday, July 27, 2022, following the ...
Chemed Corporation Announces a Five-Year $550 Million Amended and Restated Senior Secured Credit Facility
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation ("Chemed") (NYSE:CHE) announced that it has entered into $550 million of amended and restated senior secured credit facilities (“Credit Facilities”). JPMo...
Chemed (CHE) Surges 3.3%: Is This an Indication of Further Gains?
Chemed (CHE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Here's Why Investors Should Retain Chemed (CHE) Stock Now
Strong performance across Chemed's (CHE) Roto-Rooter arm and increased home-based admissions raise investors' confidence.
Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2022 Healthcare Conference on Thursday, June 9, 2022, at approximately 8:...
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
CINCINNATI--(BUSINESS WIRE)--Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2022 annual stockholders' meeting. Each of the directors continues from ...
Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022, at appr...
Chemed Corporation to Present at the Bank of America Merrill Lynch 2022 Health Care Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2022 Health Care Conference on Tuesday, May 10, 2022, ...
Chemed's (CHE) Q1 Earnings Top Estimates, Margins Increase
In Q1, Chemed's (CHE) VITAS revenue decline was primarily the result of a 4.1% decline in days of care.
Chemed (CHE) Q1 Earnings Surpass Estimates
Chemed (CHE) delivered earnings and revenue surprises of 6.68% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Chemed Reports First-Quarter 2022 Results
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the...
Here's Why You Should Hold on to Chemed (CHE) Stock For Now
Investors are optimistic about robust performance by Chemed's (CHE) Roto-Rooter arm.
Chemed To Report First-Quarter 2022 Earnings April 26, Related Conference Call To Be Held On April 27
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2022, on Tuesday, April 26, 2022, following the c...
Chemed Corporation to Present at the Oppenheimer 32nd Annual Healthcare Conference
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022, ...
Chemed (CHE) Roto-Rooter Sales Robust Despite COVID-19 Woes
Chemed's (CHE) Roto-Rooter business gains from growing demand for plumbing, drain cleaning and excavation and water restoration services.